5 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 5 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Stress: new trials by email Literature Review of Stress trials Research Report on Stress
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia Placebo, Oxytocin Intranasal Spray 12 International Unit (12IU), Oxytocin Intranasal Spray 24 International Unit (24IU) - Stress | Phase 2 | Recruiting | University of Nebraska | 32 | 2026-12-20 | 2026-11-02 |
| Sleep and Stress Study Lavender Oil, Palmitoylethanolamide (PEA), Oleoylethanolamide - Sleep Disorder (Disorder), Stress | Phase 2 | Recruiting | RDC Clinical Pty Ltd | 240 | 2026-04-07 | 2026-04-23 |
| Study of Cannabidiol and Neuroimaging on Stress Cannabidiol, Placebo - Early Life Adversity, Trauma | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 160 | 2025-10-29 | 2026-09-10 |
| Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder Magnesium vitamin B6, Placebo - Bipolar I Disorder, Depression, Anxiety | Phase 2 | Recruiting | Mclean Hospital | 40 | 2023-12-13 | 2026-06-25 |
| Effects of Rifaximin on Gut Microbiota and Emotion Rifaximin, Placebo - Healthy Volunteers, Stress | Phase 2 / Phase 3 | Recruiting | Universitaire Ziekenhuizen KU Leuven | 60 | 2023-02-02 | 2024-12-20 |
Anxiety Disorders (3) · Dementia (1) · Depression (1) · Inflammation (1) · Sleep Wake Disorders (1) · Wounds and Injuries (1)
Mental Disorders (4) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Signs and Symptoms (1)
Cannabidiol (1) · Oxytocin (1) · Rifaximin (1) · lavender oil (1) · oleoylethanolamide (1) · palmidrol (1)
Icahn School of Medicine at Mount Sinai (1) · Mclean Hospital (1) · RDC Clinical Pty Ltd (1) · Universitaire Ziekenhuizen KU Leuven (1) · University of Nebraska (1)
United States (3) · Australia (1) · Belgium (1)
Boushra Dalile, PhD (1) · Jeroen Raes, PhD (1) · Keren Bachi, PhD (1) · Kristin Verbeke, Pharm, PhD (1) · Lukas Van Oudenhove, MD, PhD (1) · RV Venkatesh (1) · Soonjo Hwang, MD (1) · Virginie-Anne Chouinard, M.D. (1)
R01MH139940 (1)